Making vaccine technology freely available to everyone sounds good. According to Professor Walter Van Dyck, patent prohibition however will slow down access to vaccine technology and, worse still, dry up innovation. To tackle the debilitating battle with the virus, you need a small number of global, capital-rich pharmaceutical companies at the heart of an ecosystem that builds on initial university research and has the scale to lead global distribution.